For: |
Jiang SJ, Dong H, Li JB, Xu LJ, Zou X, Wang KF, Lu FE, Yi P. Berberine inhibits hepatic gluconeogenesis |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7777.htm |
Number | Citing Articles |
1 |
Sukhpal Singh, Abhishek Bansal, Vikramjeet Singh, Tanya Chopra, Jit Poddar. Flavonoids, alkaloids and terpenoids: a new hope for the treatment of diabetes mellitus. Journal of Diabetes & Metabolic Disorders 2022; 21(1): 941 doi: 10.1007/s40200-021-00943-8
|
2 |
Ji Wang, Tong Wu, Li Fang, Chunlei Liu, Xiaoting Liu, Hongmei Li, Junhua Shi, Meihe Li, Weihong Min. Anti-diabetic effect by walnut (Juglans mandshurica Maxim.)-derived peptide LPLLR through inhibiting α-glucosidase and α-amylase, and alleviating insulin resistance of hepatic HepG2 cells. Journal of Functional Foods 2020; 69: 103944 doi: 10.1016/j.jff.2020.103944
|
3 |
Meixiang Chen, Nanqu Huang, Ju Liu, Juan Huang, Jingshan Shi, Feng Jin. AMPK: A bridge between diabetes mellitus and Alzheimer's disease. Behavioural Brain Research 2021; 400: 113043 doi: 10.1016/j.bbr.2020.113043
|
4 |
Zhi Wang, Kexin Nie, Hao Su, Yueheng Tang, Hongzhan Wang, Xiaohu Xu, Hui Dong. Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome. Phytomedicine 2021; 91: 153654 doi: 10.1016/j.phymed.2021.153654
|
5 |
Tapan Behl, Sukhbir Singh, Neelam Sharma, Ishrat Zahoor, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi, Simona Bungau. Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. Molecules 2022; 27(12): 3705 doi: 10.3390/molecules27123705
|
6 |
Espoir K. Kambale, Joëlle Quetin-Leclercq, Patrick B. Memvanga, Ana Beloqui. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics 2022; 14(10): 2135 doi: 10.3390/pharmaceutics14102135
|
7 |
Mikhail V. Khvostov, Elizaveta D. Gladkova, Sergey A. Borisov, Marina S. Fedotova, Nataliya A. Zhukova, Mariya K. Marenina, Yuliya V. Meshkova, Olga A. Luzina, Tatiana G. Tolstikova, Nariman F. Salakhutdinov. Study of Hypoglycemic Activity of Novel 9-N-alkyltetrahydroberberine Derivatives. International Journal of Molecular Sciences 2022; 23(22): 14186 doi: 10.3390/ijms232214186
|
8 |
Ting-ting Zhou, Tong Zhao, Fei Ma, Yi-nan Zhang, Jing Jiang, Yuan Ruan, Qiu-ying Yan, Gai-hong Wang, Jin Ren, Xiao-wei Guan, Jun Guo, Yong-hua Zhao, Ji-ming Ye, Li-hong Hu, Jing Chen, Xu Shen. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice. Acta Pharmacologica Sinica 2019; 40(9): 1193 doi: 10.1038/s41401-018-0208-2
|
9 |
Muhammed Taha KAYA, Tolga GÜVENÇ. Diyabetes Mellitusta Fitoterapinin Etkisi. Journal of Anatolian Environmental and Animal Sciences 2023; 8(3): 265 doi: 10.35229/jaes.1284154
|
10 |
Chunyan Xie, Qinhua Wang, Jing Wang, Bie Tan, Zhiyong Fan, Ze-yuan Deng, Xin Wu, Yulong Yin. Developmental changes in hepatic glucose metabolism in a newborn piglet model: A comparative analysis for suckling period and early weaning period. Biochemical and Biophysical Research Communications 2016; 470(4): 824 doi: 10.1016/j.bbrc.2016.01.114
|
11 |
Noriko Shinjyo, James Parkinson, Jimmy Bell, Tatsuro Katsuno, Annie Bligh. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Journal of Integrative Medicine 2020; 18(2): 125 doi: 10.1016/j.joim.2020.01.004
|
12 |
Jin Wang, Qian Ran, Hai-rong Zeng, Lin Wang, Chang-jiang Hu, Qin-wan Huang. Cellular stress response mechanisms of Rhizoma coptidis: a systematic review. Chinese Medicine 2018; 13(1) doi: 10.1186/s13020-018-0184-y
|
13 |
Qian Ran, Jin Wang, Lin Wang, Hai-rong Zeng, Xiang-bo Yang, Qin-wan Huang. Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00805
|
14 |
Wei-Li Yang, Chen-Yang Zhang, Wen-Yi Ji, Li-Li Zhao, Fang-Yuan Yang, Lin Zhang, Xi Cao. Berberine Metabolites Stimulate GLP-1 Secretion by Alleviating Oxidative Stress and Mitochondrial Dysfunction. The American Journal of Chinese Medicine 2024; 52(01): 253 doi: 10.1142/S0192415X24500113
|
15 |
Debajyoti Roy, Prabhjot Kaur, Maitrayee Ghosh, Deepika Choudhary, Naresh Kumar Rangra. The therapeutic potential of typical plant‐derived compounds for the management of metabolic disorders. Phytotherapy Research 2024; 38(8): 3986 doi: 10.1002/ptr.8238
|
16 |
Ying Zhong, Jing Jin, Peiyu Liu, Yu Song, Hui Zhang, Liang Sheng, Huifang Zhou, Bijie Jiang. Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/6210526
|
17 |
Mayadah Bashir Shehadeh, Ghadeer A. R. Y. Suaifan, Ala’ Mustafa Abu-Odeh. Plants Secondary Metabolites as Blood Glucose-Lowering Molecules. Molecules 2021; 26(14): 4333 doi: 10.3390/molecules26144333
|
18 |
Yuzhen Jia, Binger Xu, Jisen Xu. Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats. Pharmaceutical Biology 2017; 55(1): 510 doi: 10.1080/13880209.2016.1255649
|
19 |
Haoru Duan, Shanshan Song, Rui Li, Suqin Hu, Shuting Zhuang, Shaoyang liu, Xiaolu Li, Wei Gao. Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01432-7
|
20 |
Wenguang Chang. Non-coding RNAs and Berberine: A new mechanism of its anti-diabetic activities. European Journal of Pharmacology 2017; 795: 8 doi: 10.1016/j.ejphar.2016.11.055
|
21 |
Hesheng Liu, Xiangyang Qi, Keke Yu, Anjie Lu, Kaifeng Lin, Jiajing Zhu, Min Zhang, Zhida Sun. AMPK activation is involved in hypoglycemic and hypolipidemic activities of mogroside-rich extract from Siraitia grosvenorii (Swingle) fruits on high-fat diet/streptozotocin-induced diabetic mice. Food & Function 2019; 10(1): 151 doi: 10.1039/C8FO01486H
|
22 |
Aiyun Li, Qun Liu, Qiang Li, Baolin Liu, Yang Yang, Ning Zhang. Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1. EBioMedicine 2018; 34: 243 doi: 10.1016/j.ebiom.2018.07.039
|
23 |
Yu-Yu Jiang, Han-Ming Cui, Jia-Long Wang, Hui Liu, Meng-Meng Dang, Qiu-Yan Zhang, Fang Yang, Jian-Tao Kou, Xiao-Lin Tong. Protective role of berberine and Coptischinensis extract on T2MD rats and associated islet Rin-5f cells. Molecular Medicine Reports 2017; 16(5): 6981 doi: 10.3892/mmr.2017.7467
|
24 |
E. V. Shrayner, A. I. Khavkin, K. M. Nikolaychuk, M. F. Novikova, A. S. Veremenko, I. D. Levchenko, E. E. Vergunova, A. S. Tumas, P. Ya. Platonova, D. R. Shaimardanova, I. A. Pak, E. A. Pokushalov. The place of berberine in the treatment of metabolic syndrome. Experimental and Clinical Gastroenterology 2024; (10): 95 doi: 10.31146/1682-8658-ecg-218-10-95-103
|
25 |
Shabana Begum, Rajat Nath, Anupam Das Talukdar, Jayanta Kumar Patra, Pranab Behari Mazumder. Traditional Resources and Tools for Modern Drug Discovery. Interdisciplinary Biotechnological Advances 2024; : 551 doi: 10.1007/978-981-97-4600-2_21
|
26 |
Xiaoting Tian, Zhou Xu, Pei Hu, Yanyan Yu, Zhixiong Li, Yuanjie Ma, Mingcang Chen, Zhaolin Sun, Fang Liu, Jingya Li, Chenggang Huang. Determination of the antidiabetic chemical basis of Phellodendri Chinensis Cortex by integrating hepatic disposition in vivo and hepatic gluconeogenese inhibition in vitro. Journal of Ethnopharmacology 2020; 263: 113215 doi: 10.1016/j.jep.2020.113215
|
27 |
Li Lu, Xiaodong Sun, Yating Qin, Xiaomei Guo. The Signaling Pathways Involved in the Antiatherosclerotic Effects Produced by Chinese Herbal Medicines. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/5392375
|
28 |
Jae Eun Park, Ji Sook Han. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell. European Journal of Pharmacology 2022; 928: 175108 doi: 10.1016/j.ejphar.2022.175108
|
29 |
Zahra Ilyas, Simone Perna, Salwa Al-thawadi, Tariq A. Alalwan, Antonella Riva, Giovanna Petrangolini, Clara Gasparri, Vittoria Infantino, Gabriella Peroni, Mariangela Rondanelli. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Biomedicine & Pharmacotherapy 2020; 127: 110137 doi: 10.1016/j.biopha.2020.110137
|
30 |
Seong Lin Teoh, Srijit Das. Phytochemicals and their effective role in the treatment of diabetes mellitus: a short review. Phytochemistry Reviews 2018; 17(5): 1111 doi: 10.1007/s11101-018-9575-z
|
31 |
Chu Shufang, Zhou Yinan, Li Huilin, Zhao Hengxia, Liu Deliang, Liu Xuemei. Effect of He Qi San on DNA Methylation in Type 2 Diabetes Mellitus Patients with Phlegm-blood Stasis Syndrome. Open Chemistry 2019; 17(1): 1213 doi: 10.1515/chem-2019-0130
|
32 |
Xiaofang Guo, Xiwen Xiong, Lijun Zhao, Genshen Zhong, Xiaofei Zhu. Anti-Aging Pharmacology. 2023; : 305 doi: 10.1016/B978-0-12-823679-6.00020-5
|
33 |
Zixia Wang, Dan Xu, Linlin She, Yirui Zhang, Qingli Wei, Jiye Aa, Guangji Wang, Baolin Liu, Yuan Xie. Curcumin restrains hepatic glucose production by blocking cAMP/PKA signaling and reducing acetyl CoA accumulation in high-fat diet (HFD)-fed mice. Molecular and Cellular Endocrinology 2018; 474: 127 doi: 10.1016/j.mce.2018.02.018
|
34 |
Yi Shi, Banghua Zhou, Liqiong Yu, Yaqin Liu, Yunfeng Han, Xi Tang, Xianrong Lai, Mohammed Bourhia. Understanding of Diabetes in Tibetan, Mongolian, Miao, Dai, Uygur, and Yi Medicine and Collation of Prevention and Cure Medicines. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/9308598
|
35 |
Yaping Liang, Xiaojia Xu, Mingjuan Yin, Yan Zhang, Lingfeng Huang, Ruoling Chen, Jindong Ni. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocrine Journal 2019; 66(1): 51 doi: 10.1507/endocrj.EJ18-0109
|
36 |
Xinmei Xu, Huan Yi, Jiasi Wu, Tingting Kuang, Jing Zhang, Qi Li, Huan Du, Tong Xu, Guihua Jiang, Gang Fan. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomedicine & Pharmacotherapy 2021; 133: 110984 doi: 10.1016/j.biopha.2020.110984
|
37 |
Doudou Wang, Lin Yang, Wenwen Ding, Ziyi Chen, Xiaoxue Yang, Yu Jiang, Ying Liu. Licochalcone A alleviates abnormal glucolipid metabolism and restores energy homeostasis in diet‐induced diabetic mice. Phytotherapy Research 2024; 38(1): 196 doi: 10.1002/ptr.8044
|
38 |
Udaiyar Muruganathan, Subramani Srinivasan, Veerasamy Vinothkumar. Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic β-cell apoptosis in streptozotocin–nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes. Biomedicine & Pharmacotherapy 2017; 92: 229 doi: 10.1016/j.biopha.2017.05.068
|
39 |
Zhu-Jun Mao, Min Lin, Xin Zhang, Lu-Ping Qin. Combined Use of Astragalus Polysaccharide and Berberine Attenuates Insulin Resistance in IR-HepG2 Cells via Regulation of the Gluconeogenesis Signaling Pathway. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01508
|
40 |
Maria-Ioanna Christodoulou, Job Tchoumtchoua , Alexios-Leandros Skaltsounis , Andreas Scorilas, Maria Halabalaki . Natural Alkaloids Intervening the Insulin Pathway: New Hopes for Anti-Diabetic Agents?. Current Medicinal Chemistry 2019; 26(32): 5982 doi: 10.2174/0929867325666180430152618
|
41 |
Shengjie Yang, Dan Li, Zongliang Yu, Yujuan Li, Min Wu. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.709629
|
42 |
Lei Wang, Gladstone Sagada, Chenyang Wang, Chang Gao, Bin Wang, Qingjun Shao, Yunzhi Yan. Berberine in fish nutrition: Impact on hepatoenteric health, antioxidative and immune status. Frontiers in Marine Science 2022; 9 doi: 10.3389/fmars.2022.967748
|
43 |
Min Lin, Zhu-Jun Mao. lncRNA–mRNA competing endogenous RNA network in IR-hepG2 cells ameliorated by APBBR decreasing ROS levels: a systematic analysis. PeerJ 2020; 8: e8604 doi: 10.7717/peerj.8604
|
44 |
Ramachandran Vinayagam, Jianbo Xiao, Baojun Xu. An insight into anti-diabetic properties of dietary phytochemicals. Phytochemistry Reviews 2017; 16(3): 535 doi: 10.1007/s11101-017-9496-2
|
45 |
Vahid Reza Askari, Kimia Khosravi, Vafa Baradaran Rahimi, Stefania Garzoli. A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects. Pharmaceuticals 2023; 17(1): 7 doi: 10.3390/ph17010007
|
46 |
Tarun Belwal, Aarti Bisht, Hari Prasad Devkota, Hammad Ullah, Haroon Khan, Aseesh Pandey, Indra Dutt Bhatt, Javier Echeverría. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00041
|
47 |
Yidi Wang, Huaibo Yuan, Xi Chen, Tingting Zeng. Effect of water caltrop (Trapa bispinosaRoxb.) pericarp extract on improving insulin resistance in STZ-induced diabetic mice. Pharmacological Research - Modern Chinese Medicine 2021; 1: 100015 doi: 10.1016/j.prmcm.2021.100015
|
48 |
Hong-Yu Xu, Chang-Shun Liu, Chuan-Li Huang, Li Chen, Yu-Rong Zheng, Si-Hang Huang, Xiao-Ying Long. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge. Colloids and Surfaces B: Biointerfaces 2019; 181: 927 doi: 10.1016/j.colsurfb.2019.06.006
|
49 |
Michalina Mróz, Katarzyna Pastusiak, Paweł Bogdański. Potencjalne możliwości wykorzystania berberyny w przeciwdziałaniu insulinooporności i w cukrzycy typu 2. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 790 doi: 10.2478/ahem-2021-0038
|
50 |
Hammad Ullah, Maria Daglia. The Role of Phytonutrients in Metabolic Disorders. 2022; : 163 doi: 10.1016/B978-0-12-824356-5.00011-4
|
51 |
Yulong Cui, Quanying Zhou, Min Jin, Siqi Jiang, Peizhao Shang, Xiaofan Dong, Lingjun Li. Research progress on pharmacological effects and bioavailability of berberine. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(11): 8485 doi: 10.1007/s00210-024-03199-0
|
52 |
Kavishankar Gawli, Kavya Sritha Bojja. Molecules and targets of antidiabetic interest. Phytomedicine Plus 2024; 4(1): 100506 doi: 10.1016/j.phyplu.2023.100506
|
53 |
Daniel E. Lefever, Joella Xu, Yingjia Chen, Guannan Huang, Nagy Tamas, Tai L. Guo. TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice. Toxicology and Applied Pharmacology 2016; 304: 48 doi: 10.1016/j.taap.2016.05.016
|
54 |
Naomi Rozentul, Yosef Avrahami, Moran Shubely, Laura Levy, Anna Munder, Guy Cohen, Erol Cerasi, Shlomo Sasson, Arie Gruzman. A Novel Phenylchromane Derivative Increases the Rate of Glucose Uptake in L6 Myotubes and Augments Insulin Secretion from Pancreatic Beta-Cells by Activating AMPK. Pharmaceutical Research 2017; 34(12): 2873 doi: 10.1007/s11095-017-2271-7
|
55 |
Chang-Shun Liu, Yu-Rong Zheng, Ying-Feng Zhang, Xiao-Ying Long. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 2016; 109: 274 doi: 10.1016/j.fitote.2016.02.001
|
56 |
Dongqing Jiang, Dianhui Wang, Xianghua Zhuang, Zhanqing Wang, Yihong Ni, Shihong Chen, Fudun Sun. Berberine increases adipose triglyceride lipase in 3T3-L1 adipocytes through the AMPK pathway. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0383-4
|
57 |
Wen Sun, Guangyuan Xu, Xuan Guo, Guangbin Luo, Lili Wu, Yi Hou, Xiangyu Guo, Jingxin Zhou, Tunhai Xu, Lingling Qin, Yixin Fan, Li Han, Motlalepula Matsabisa, Xuesheng Ma, Tonghua Liu. Protective effects of asiatic acid in a spontaneous type 2 diabetic mouse model. Molecular Medicine Reports 2017; 16(2): 1333 doi: 10.3892/mmr.2017.6684
|
58 |
Md Ali Mujtaba, Md Habban Akhter, Md. Sarfaraz Alam, Mohammad Daud Ali, Afzal Hussain. An Updated Review on Therapeutic Potential and Recent Advances in Drug Delivery of Berberine: Current Status and Future Prospect. Current Pharmaceutical Biotechnology 2022; 23(1): 60 doi: 10.2174/1389201022666210208152113
|
59 |
Su-Ryun Jung, Ji-Hye Lee, Hanguk Ryu, Yurong Gao, Jaemin Lee. Lithium and exercise ameliorate insulin-deficient hyperglycemia by independently attenuating pancreatic α-cell mass and hepatic gluconeogenesis. The Korean Journal of Physiology & Pharmacology 2024; 28(1): 31 doi: 10.4196/kjpp.2024.28.1.31
|
60 |
Syed Afroz Ali, Ashok Kumar Datusalia. Berberine attenuates ECM accumulation and the progression of acute liver failure through inhibition of NLRP3 inflammasome signalling. Toxicology and Applied Pharmacology 2024; 492: 117129 doi: 10.1016/j.taap.2024.117129
|
61 |
Cunsi Ye, Yajing Zhang, Shaomin Lin, Yi Chen, Zimiao Wang, Haoyinghua Feng, Guangqing Fang, Shijian Quan. Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions. Molecules 2023; 28(4): 1874 doi: 10.3390/molecules28041874
|
62 |
Guoyan Wang, Yuanyuan Zhu, Dingping Feng, Junhu Yao, Yangchun Cao, Lu Deng. Hepatic gluconeogenesis and regulatory mechanisms in lactating ruminants: A literature review. Animal Research and One Health 2024; doi: 10.1002/aro2.80
|
63 |
Yunfeng Han, Yunan Xiang, Yi Shi, Xi Tang, Lin Pan, Jie Gao, Ruohong Bi, Xianrong Lai, Ahmed Mediani. Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/9987097
|
64 |
Qian-Jia Liu, Wei Yuan, Ping Yang, Chen Shao. Role of glycolysis in diabetic atherosclerosis. World Journal of Diabetes 2023; 14(10): 1478-1492 doi: 10.4239/wjd.v14.i10.1478
Abstract(568) |
Core Tip(439) |
Full Article(HTML)(2766)
|
Full Article with Cover (PDF)-3007K(85)
|
Full Article (Word)-35890K(36)
|
Audio-1690K(6)
|
Peer-Review Report-332K(53)
|
Answering Reviewers-284K(47)
|
Full Article (PDF)-2701K(182)
|
Full Article (XML)-260K(63)
|
Times Cited (0)
|
Total Visits (5409)
|
Open
|
65 |
Xiao Li, Xiaowei Sun, Li Li, Yao Luo, Yingjie Chi, Guangying Zheng. MDM2-mediated ubiquitination of LKB1 contributes to the development of diabetic cataract. Experimental Cell Research 2022; 417(1): 113191 doi: 10.1016/j.yexcr.2022.113191
|
66 |
Xueling Ma, Zhongjun Chen, Le Wang, Gesheng Wang, Zihui Wang, XiaoBo Dong, Binyu Wen, Zhichen Zhang. The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00782
|
67 |
Weiwei Wang, Wenjian Yang, Yi Dai, Jianhui Liu, Zhen-Yu Chen. Production of Food-Derived Bioactive Peptides with Potential Application in the Management of Diabetes and Obesity: A Review. Journal of Agricultural and Food Chemistry 2023; doi: 10.1021/acs.jafc.2c08835
|
68 |
Xiao-hu Xu, Qian Hu, Li-shan Zhou, Li-jun Xu, Xin Zou, Fu-er Lu, Ping Yi. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway. Current Medical Science 2020; 40(3): 530 doi: 10.1007/s11596-020-2210-4
|
69 |
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, Sriwidodo Sriwidodo. A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant. Molecules 2023; 28(3): 1294 doi: 10.3390/molecules28031294
|